Jaguar Health (JAGX) to Release Earnings on Wednesday

Jaguar Health (NASDAQ:JAGX) is scheduled to post its quarterly earnings results before the market opens on Wednesday, November 13th.

Jaguar Health (NASDAQ:JAGX) last released its earnings results on Tuesday, August 13th. The biotechnology company reported ($4.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.20) by ($2.84). Jaguar Health had a negative net margin of 350.18% and a negative return on equity of 412.63%. The business had revenue of $2.72 million during the quarter. On average, analysts expect Jaguar Health to post $-1 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Jaguar Health Price Performance

Shares of JAGX stock opened at $0.92 on Tuesday. The stock has a 50 day moving average of $1.15 and a 200-day moving average of $3.86. The company has a current ratio of 2.10, a quick ratio of 1.60 and a debt-to-equity ratio of 1.32. Jaguar Health has a 12 month low of $0.90 and a 12 month high of $30.86.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of Jaguar Health from a “sell” rating to a “hold” rating in a report on Friday, September 13th.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.